Dr. Tovit Rosenzweig of Ariel University has discovered that the Israeli plant Sarcopoterium Spinosum (sira kotzanit / thorny burnet) can balance blood sugar levels. Dr. Rosenzweig is developing a treatment from the plant that could benefit more than 200 million … Continue reading →

Israel’s Therapix Biosciences is conducting a proof-of-concept Phase II clinical study with the Hannover Medical School, of its lead compound THX-TS01 for 20 patients suffering from Tourette Syndrome. http://www.prnewswire.com/news-releases/therapix-biosciences-and-the-hannover-medical-school-enter-into-an-investigator-initiated-clinical-trial-agreement-to-assess-the-effect-of-txh-ts01-in-patients-with-tourette-syndrome-300453033.html

Final results of BiondVax’s Phase 2b trials of its Universal Flu vaccine confirmed preliminary results reported here previously. (5 Feb) Both endpoints were met. Immune response to the vaccine was statistically significant. BiondVax can now proceed to Phase 3 final … Continue reading →

I reported previously (Apr 2014) on Israel’s Entera Bio which is testing treatments for disorders in the parathyroid gland, and osteoporosis. Entera Bio has now filed for floating the biotech on NASDAQ to fund Phase II/III trials of its treatment … Continue reading →

A research team from Israel’s Bar-Ilan University has developed “Prophecy” – a first-ever formula that lets hyaluronic acid penetrate the deeper skin layers, to smooth out wrinkles using a cream and without injection. Hyaluronic acid absorbs water to smooth the … Continue reading →

Israeli charity Ezer Mizion recently hosted a major conference on Alternative and Augmentative Communication (AAC).  The aim of the conference was to share the cutting-edge knowledge that Ezer Mizion has been advancing.  Those on Facebook please watch the video of … Continue reading →

The ReWalk is an FDA approved exoskeleton that allows individuals with spinal-cord injuries to stand, walk, and move freely. Israel’s Re-Walk has already helped more than 100 paraplegics take their first steps towards mobility – some can be seen in … Continue reading →

Israel’s Insightec has been granted US FDA approval to use its Exablate Neuro system with 1.5T MRI – the most common MRI system in use today.  It should vastly expand the use of Insightec’s successful non-invasive focused ultrasound treatment for … Continue reading →